Category:Immunosuppressive monoclonal antibodies

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

A class of monoclonal antibodies intended to cause an immunosuppressant effect. This can be a primary intended effect or a side effect of treatment (e.g., the use of rituximab in malignancy will have a side effect of immunosuppression).